Consumers in the U.S. are increasingly finding it harder to trust the brands they do business with. This is why Newsweek is ...
Truist downgraded Sabra Health Care (SBRA) to Hold from Buy with a price target of $17, down from $18.Stay Ahead of the Market:Discover ...
Truist analyst Michael Lewis downgraded Sabra Health Care (SBRA) to Hold from Buy with a price target of $17, down from $18. The firm cites ...